Systemic diseases and their treatments in the elderly: impact on oral health.
The lifespan of the US population is increasing, with the elderly desiring successful aging. This goal is jeopardized as multiple systemic conditions and their treatments become more prevalent with age, causing impaired systemic and oral health and influencing an older person's quality of life. To obtain successful aging, a compression of morbidity must be obtained through prevention and management of disease. This paper describes the most common systemic diseases causing morbidity and mortality in persons aged 65+ years: diseases of the heart, malignant neoplasms, cerebrovascular diseases, chronic obstructive pulmonary disease, pneumonia, influenza, diabetes mellitus, trauma, Alzheimer's disease, renal diseases, septicemia, and liver diseases. Disease prevalence and the impact of medications and other therapeutic measures used to treat these conditions are discussed. Oral sequelae are reviewed with guidelines for early detection of these deleterious consequences, considerations for oral treatment, and patient management. An understanding of the impact of systemic diseases and treatment on oral health is imperative for dental practitioners to appropriately treat and manage older patients with these conditions. With a focus on early detection and prevention, oral health care providers can improve the quality of life of this population and aid in the attainment of successful aging.
University of North Carolina at Chapel Hill, School of Dentistry, USA.
E M
EM
Ghezzi
J A
JA
Ship
D000368:Aged; D000375:Aging / Q000502:physiology*; D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D004194:Disease; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D006331:Heart Diseases / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology; D008107:Liver Diseases / Q000188:drug therapy / Q000503:physiopathology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000503:physiopathology; D009059:Mouth Diseases / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D011014:Pneumonia / Q000188:drug therapy / Q000503:physiopathology; D015995:Prevalence; D011788:Quality of Life; D018805:Sepsis / Q000188:drug therapy / Q000503:physiopathology; D014947:Wounds and Injuries / Q000188:drug therapy / Q000503:physiopathology